Zemanick Karen B MD is categorized under Business Services (Unclassified) in Chicago, IL and active since 2013.
Zemanick Karen B MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Karen Zemanick at the company’s single location by writing to 3225 North Sheffield Avenue, Chicago, Illinois IL 60657 or by phoning (773) 549-5886. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Zemanick Karen B MD |
| Contact Person: | Karen Zemanick |
| Address: | 3225 North Sheffield Avenue, Chicago, Illinois 60657 |
| Phone Number: | (773) 549-5886 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Zemanick Karen B MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Karen Zemanick for inquiries that concern Zemanick Karen B MD by calling the company number (773) 549-5886, as your correspondence is most welcome. Additionally, the physical location of the single location of Zemanick Karen B MD can be found at the coordinates 41.940813,-87.654057 as well as the street address 3225 North Sheffield Avenue in Chicago, Illinois 60657.
For its online presence, you may visit Zemanick Karen B MD’s website at and engage with its social media outlets through on Twitter and on Facebook.